01568nas a2200373 4500000000100000008004100001260001700042653001500059653001000074653001400084653002100098653001700119653000900136653001100145653001100156653001200167653001000179653000900189653001600198653002300214653002800237653001500265653001800280653001700298653002100315653002600336100001500362700001800377245007400395300001300469490000600482520069200488022001401180 2000 d c2000 Sep-Nov10aAdolescent10aAdult10aAftercare10aAge Distribution10aAge of Onset10aAged10aFemale10aHumans10aleprosy10aLibya10aMale10aMiddle Aged10aPatient Compliance10aPopulation Surveillance10aPrevalence10aPublic health10aRisk Factors10aSex Distribution10aSocioeconomic Factors1 aToweir A A1 aChaudhary R C00aReview of leprosy cases in Benghazi, Libyan Arab Jamahiriya, 1994-98. a1098-1020 v63 a
A descriptive study was conducted using case records from the Leprosy Clinic, Benghazi for the period 1994-98. A constant decline in the number of leprosy cases registered for multidrug treatment (MDT) was observed, from 18 in 1994 to 4 in 1998. The ratio of multibacillary to paucibacillary cases was 1.3:1. Most of the patients were young male adults who were socially and economically productive. An hypopigmented patch was the most common lesion present on easily accessible sites. Early registration, compliance with MDT and follow-up will enhance the cure rate and lead to a reduction in disability rates. Despite elimination surveillance for new leprosy cases is essential.
a1020-3397